Get Daily Stock Reports

StockReport.com is a 7:00 PM newsletter with a pertinent stock report every day, plus the lates market news.

Stock of the Day: Novo Nordisk A/S

Novo Nordisk A/S
NVO 90-day performance NYSE:NVO Novo Nordisk A/S
Current Price
$51.40
-1.00 (-1.90%)
(As of 12/29/2025 03:59 PM ET)
30 Day Performance
4.17%
  
 
90 Day Performance
-13.09%
  
  
1 Year Performance
-40.04%
  
  
Market Capitalization
$229.51B
P/E Ratio
14.94
Dividend Yield
1.60%

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, best known for its leadership in diabetes care and metabolic health. The company traces its roots to early Danish insulin production in the 1920s and was established in its current form through a 1989 merger of predecessor companies. Novo Nordisk develops, manufactures and markets pharmaceutical products and devices that address chronic and serious diseases, with a strong emphasis on long-term treatment and patient support.

The company’s core product portfolio centers on diabetes therapies, including a range of insulins and modern incretin-based treatments. Novo Nordisk has been a major commercial and scientific driver of GLP-1 receptor agonists, marketed under well-known brand names for glucose control and weight management. In addition to diabetes and obesity medicines, the company supplies treatments for haemophilia and other rare bleeding disorders, as well as growth disorders and hormone replacement therapies. Its offerings combine pharmaceuticals with delivery devices and patient services aimed at improving adherence and outcomes.

Research and development are central to Novo Nordisk’s strategy, with continued investment in next-generation medicines for metabolic, cardiovascular and rare diseases. The company operates global manufacturing and distribution networks and markets its products broadly, with significant commercial operations in the United States, Europe and other international markets. Novo Nordisk also engages in partnerships and licensing arrangements with academic institutions, biotechnology firms and healthcare organizations to support innovation and expand access to therapies.

Leadership is focused on long-term innovation and patient-centric care; the company is led by President and CEO Lars Fruergaard Jørgensen. Novo Nordisk positions itself as a specialist pharmaceutical company with a mission to improve the lives of people with chronic conditions through medical innovation, comprehensive treatment solutions and support services for patients and healthcare providers.

Read Full Report

More recent reports:

Applied Digital logo
APLD 90-day price performance12/28/2025

Applied Digital Stock Report

Applied Digital (NASDAQ: APLD) is a technology company specializing in the development and operation of large-scale digital infrastructure and sustainable Bitcoin mining solutions. Through its integrated platform, the company designs, builds and manages turnkey data center facilities while also providing comprehensive hosting services for cloud, co
Read Report ▸
Aramark logo
ARMK 90-day price performance12/27/2025

Aramark Stock Report

Aramark (NYSE: ARMK) is a global provider of food services, facilities management and uniform solutions, serving clients across a wide array of industries including education, healthcare, business and government. The company operates through three primary segments: Food and Support Services, Uniform and Career Apparel, and Facility Services, delive
Read Report ▸
Motorola Solutions logo
MSI 90-day price performance12/26/2025

Motorola Solutions Stock Report

Motorola Solutions, Inc. is a provider of mission-critical communications and analytics solutions for public safety and commercial customers. The company designs, manufactures and supports a range of communications equipment and software aimed at enabling first responders, government agencies and enterprises to coordinate and operate reliably in hi
Read Report ▸
Morgan Stanley logo
MS 90-day price performance12/25/2025

Morgan Stanley Stock Report

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadershi
Read Report ▸

Read your StockReport.com newsletter to keep up with the hottest companies..